comparemela.com

Latest Breaking News On - Muliang viagoo technology - Page 1 : comparemela.com

Form 10-K/A MULIANG VIAGOO TECHNOLOG For: Dec 31

Form 10-K/A MULIANG VIAGOO TECHNOLOG For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bit Origin : PROXY STATEMENT AND NOTICE OF ANNUAL GENERAL MEETING - Form 6-K

China Digest: Muliang eyes $40m Nasdaq IPO; neoX Biotech, Resproly raise fresh capital

China Digest: Muliang eyes $40m Nasdaq IPO; neoX Biotech, Resproly raise fresh capital Source: Markus Winkler/Unsplash February 2, 2021 Chinese fertiliser producer Muliang is seeking to raise $40 million in a Nasdaq IPO, while biotech startup neoX Biotech and inhalation therapy developer Resproly have closed new funding rounds to expand operations. Fertiliser producer Muliang to raise $40m in Nasdaq IPO Chinese fertiliser producer Muliang Viagoo Technology (MLVG) is seeking to raise $40 million on the Nasdaq this week by offering 10 million shares at a price of $4 apiece. At the proposed deal size, Muliang would command a market cap of $194 million. Formed in 2014 under the laws of the state of Nevada, US, Muliang conducts business primarily through Shanghai Muliang, a variable interest entity (VIE) created under the laws of China, to engage in the manufacturing and distribution of organic fertilisers and the sales of agricultural products in China. Its organic fertiliser produ

Initial public offerings scheduled to debut next week

Initial public offerings scheduled to debut next week
sfgate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfgate.com Daily Mail and Mail on Sunday newspapers.

Initial public offerings scheduled to debut next week

Initial public offerings scheduled to debut next week by The Associated Press Last Updated Dec 11, 2020 at 2:58 pm EDT NEW YORK The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. Week of Dec. 14 BioAlta – San Diego, 9.4 million shares, priced $15-$17, managed by JP Morgan/Jefferies. Proposed Nasdaq symbol BCAB. Business: Phase 2 biotech developing selective antibody therapies for solid tumors. Dune Acquisition – West Palm Beach, Fla., 13 million shares, priced at $10, managed by Cantor Fizgerald/Needham & Co. Proposed Nasdaq symbol DUNEU. Business: Blank check company formed by executives from delta2 Capital targeting a SaaS business.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.